Valeant slashes stake in Allergan after losing bid
November 20, 2014 at 19:14 PM EST
Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker.
